Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2024-12-16 Major Shareholding Noti…
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Zawiadomienie o zmianie stanu posiadania - art 69 ust 2 pkt 1 a Ustawy o Ofercie - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is extremely short (162 characters) and states that the Management Board of Biomaxima SA is providing a notification regarding a Shareholders' Agreement change, with the content of the notification being in an attachment ("treść zawiadomioenia w załaczniku"). According to the 'MENU VS MEAL' rule, a short announcement stating that the actual content is attached or published elsewhere should be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this is a specific notification about a change in shareholding/agreement, and it is being announced rather than containing the full details, RPA is a strong candidate, but RNS is the most appropriate fallback for general regulatory announcements that don't fit specific categories like DIRS or MRQ, especially when the core content is external. Given the nature of announcing a document/notification, RPA is highly suitable, but RNS covers general regulatory announcements. Since the content relates to shareholder agreements/holdings, it is a regulatory disclosure. I will classify it as RNS as it is a general regulatory announcement whose full content is external, fitting the short announcement criteria.
2024-12-16 Polish
Zawiadomienie od Przewodniczącego Rady Nadzorczej
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transaction(s) referred to in Article 19(1) of the MAR Regulation). It details share transactions (Nabycie/Zbycie - Acquisition/Disposal) made by a person discharging managerial responsibilities ('Przewodniczący Rady Nadzorczej' - Chairman of the Supervisory Board) in the company's shares. This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided categories. The specific code for this is DIRS.
2024-12-16 Polish
Zawiadomienie od osoby zobowiązanej - Content (PL)
Board/Management Information Classification · 99% confidence The document text is extremely short (132 characters) and states that the Management Board (Zarząd) of BioMaxima SA is making public a notification received from the Chairman of the Supervisory Board (Przewodniczącego Rady Nadzorczej). This structure strongly suggests a formal announcement regarding a specific event or communication, rather than a comprehensive report (like 10-K or IR). Since the content relates to a notification received by management concerning a board member's action or communication, it most closely aligns with Board/Management Information (MANG) or potentially a general Regulatory Filing (RNS) if it concerns insider dealings or governance changes. Given the reference to the Chairman of the Supervisory Board, MANG is the most specific fit for management/board-related announcements that aren't explicitly director dealings (DIRS) or remuneration (DEF 14A). However, because the text is just a notification of a notification, and lacks specific details about management changes, the safest classification for a very brief, non-standard announcement is the general Regulatory Filings category (RNS), as per Rule 2 (Menu vs Meal) and Rule 3 (Fallback).
2024-12-16 Polish
Zawiadomienie od członka Rady Nadzorczej
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction (Nabycie - Acquisition) of shares by a member of the Supervisory Board (Krzysztof Mikosz) of the company BioMaxima Spółka Akcyjna. Article 19 of the Market Abuse Regulation (MAR) specifically governs notifications of transactions conducted by persons discharging managerial responsibilities (PDMRs). This directly corresponds to the definition of Director's Dealing (insider trades). Comparing this to the provided definitions: - 10-K, AR, IR are comprehensive financial reports. - ER, MRQ are earnings/quarterly reports. - The content is a specific report of personal share transactions by an executive/director. - This matches the definition for Director's Dealing (Code: DIRS).
2024-12-10 Polish
Zawiadomienie od osoby zobowiązanej - Content (PL)
Board/Management Information Classification · 99% confidence The document text is extremely short (123 characters) and states that the Management Board (Zarząd) of BioMaxima SA is making public a notification received from a member of the Supervisory Board (Rady Nadzorczej). This structure strongly suggests an insider transaction notification or a change in board/management interest, which falls under Director's Dealing (DIRS) or Board/Management Information (MANG). Given the context of a notification received from a Supervisory Board member regarding some action, Director's Dealing (DIRS) is the most specific fit for reporting executive transactions, although MANG is also plausible if it relates to a change in position. Since the text mentions a 'notification received from a member of the Supervisory Board,' this is highly indicative of insider activity reporting, which is classified as DIRS.
2024-12-10 Polish
Raport Grupy Kapitałowej za 3 kwartały 2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Raport Grupy Kapitałowej BioMaxima SA' for the 9-month period ending September 30, 2024. It contains a letter from the CEO, detailed financial statements (consolidated statement of profit or loss, financial position, cash flows), and extensive explanatory notes. This constitutes a comprehensive interim financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-29 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.